DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,145,594 | +2.3% | 20,740 | -1.0% | 0.14% | +6.7% |
| Q2 2023 | $5,027,520 | -3.2% | 20,948 | +1.7% | 0.13% | -1.5% |
| Q1 2023 | $5,192,780 | -4.7% | 20,603 | +0.3% | 0.14% | -6.2% |
| Q4 2022 | $5,450,400 | -13.2% | 20,535 | -15.6% | 0.14% | -9.4% |
| Q3 2022 | $6,281,000 | -14.8% | 24,317 | -16.4% | 0.16% | -6.4% |
| Q2 2022 | $7,371,000 | -11.9% | 29,074 | +2.0% | 0.17% | -10.0% |
| Q1 2022 | $8,365,000 | -19.3% | 28,517 | -9.5% | 0.19% | -6.4% |
| Q4 2021 | $10,362,000 | +6.9% | 31,495 | -1.1% | 0.20% | +2.5% |
| Q3 2021 | $9,693,000 | +25.3% | 31,840 | +10.4% | 0.20% | +44.5% |
| Q2 2021 | $7,737,000 | +19.6% | 28,829 | +0.3% | 0.14% | +20.2% |
| Q1 2021 | $6,468,000 | -16.1% | 28,736 | -17.2% | 0.11% | +10.7% |
| Q4 2020 | $7,707,000 | +26.1% | 34,696 | +0.4% | 0.10% | +21.2% |
| Q3 2020 | $6,112,000 | 0.0% | 34,567 | 0.0% | 0.08% | 0.0% |
| Q2 2020 | $6,112,000 | +32.5% | 34,567 | +3.7% | 0.08% | +21.4% |
| Q1 2020 | $4,613,000 | +21.0% | 33,325 | +34.2% | 0.07% | +1.4% |
| Q4 2019 | $3,811,000 | +8.5% | 24,833 | +2.1% | 0.07% | -10.4% |
| Q3 2019 | $3,512,000 | +2.8% | 24,314 | +1.7% | 0.08% | -3.8% |
| Q2 2019 | $3,415,000 | -72.9% | 23,897 | -75.0% | 0.08% | -65.1% |
| Q1 2019 | $12,604,000 | +31.6% | 95,474 | +2.8% | 0.23% | +43.1% |
| Q4 2018 | $9,581,000 | -18.2% | 92,915 | -13.8% | 0.16% | -10.1% |
| Q3 2018 | $11,709,000 | +0.8% | 107,757 | -8.5% | 0.18% | +2.9% |
| Q2 2018 | $11,617,000 | +6.2% | 117,721 | +5.4% | 0.17% | -4.9% |
| Q1 2018 | $10,940,000 | -14.8% | 111,736 | -19.2% | 0.18% | -14.2% |
| Q4 2017 | $12,834,000 | +9.2% | 138,265 | +0.9% | 0.21% | +9.8% |
| Q3 2017 | $11,757,000 | -0.6% | 137,060 | -2.2% | 0.19% | -3.5% |
| Q2 2017 | $11,829,000 | +12.1% | 140,168 | +13.7% | 0.20% | +7.0% |
| Q1 2017 | $10,548,000 | +93.9% | 123,325 | +76.4% | 0.19% | +74.8% |
| Q4 2016 | $5,441,000 | +15.4% | 69,895 | +16.3% | 0.11% | +8.1% |
| Q3 2016 | $4,713,000 | +104.1% | 60,118 | +163.0% | 0.10% | +102.0% |
| Q2 2016 | $2,309,000 | +6.7% | 22,858 | +0.1% | 0.05% | +4.3% |
| Q1 2016 | $2,165,000 | +2.9% | 22,825 | +0.8% | 0.05% | +6.8% |
| Q4 2015 | $2,104,000 | +8.3% | 22,649 | -0.6% | 0.04% | +7.3% |
| Q3 2015 | $1,942,000 | -0.1% | 22,786 | +0.4% | 0.04% | +5.1% |
| Q2 2015 | $1,943,000 | +2.4% | 22,706 | +1.6% | 0.04% | 0.0% |
| Q1 2015 | $1,898,000 | – | 22,354 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |